A groundbreaking platform has revealed the intricate choreography of mammalian transcription, shedding light on the complex dance of RNA polymerase II (Pol II) and its regulatory proteins. This enzyme, responsible for transcribing DNA into RNA, must move in perfect harmony with other biological processes, and any disruptions can lead to cancer and aging. However, understanding its precise movement and the factors governing its pauses and accelerations has been challenging due to technical limitations.
The new study, published in Nature Structural & Molecular Biology, employs a single-molecule platform to observe individual mammalian transcription complexes in action. This approach provides a clear view of how this molecular engine accelerates, pauses, and shifts gears as it transcribes genetic information, almost like a finely tuned automobile with multiple gears.
Shixin Liu, head of the Laboratory of Nanoscale Biophysics and Biochemistry, explains, "We figured out, for the first time, how each gear is controlled." This platform, developed in collaboration with Joel E. Cohen from the Laboratory of Populations, allowed researchers to objectively assess when the machine shifts gears and how fast it goes.
The study reveals that Pol II's movement is governed by several key regulatory proteins. P-TEFb acts as a master switch, phosphorylating both Pol II and a protein complex, DSIF, to unlock its full activity. PAF1C, a main accelerator, snaps transcription into motion upon binding DNA, while SPT6 stabilizes PAF1C's attachment, ensuring smooth operation. RTF1, another factor, provides an additional boost in transcription speed and switches Pol II to high gear, a step dependent on PAF1C but not DSIF.
These findings offer new insights into how disruptions in this control may contribute to cancer and aging, particularly in factors like P-TEFb, a promising drug target for leukemia and solid tumors. The platform itself is a significant achievement, proving that single-molecule visualization is possible in a fully reconstituted mammalian system, opening doors for future research and applications.
The computational component of the platform has potential far beyond transcription. "Anything that involves navigation in space and changes in speed could potentially use this software," suggests Cohen. This breakthrough not only enhances our understanding of transcription but also paves the way for novel therapeutic approaches and biological research.
